Rational Drug Development Using Gene-Targeted Agents and Their Application in Anti-Gene Radiotherapy
Journal:
Current Genomics
Volume:
4
Page:
275-294
Author(s):
Thomas A. Winters, Elzbieta Pastwa, Kamal Datta and Ronald D. Neumann
Apoptosis in Drug Response
Journal:
Current Pharmacogenomics
Volume:
1
Page:
9-16
Author(s):
Simone Fulda and Klaus-Michael Debatin
Genetic Polymorphism and Tumor Immunotherapy
Journal:
Current Pharmacogenomics
Volume:
1
Page:
37-57
Author(s):
Rongcun Yang and Richard B.S. Roden
Vascular Endothelial Cell Growth Factor (VEGF), An Emerging Target for Cancer Chemotherapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
95-117
Author(s):
S. Shinkaruk, M. Bayle, G. Lain and G. Deleris
New Approach to Cancer Therapy: The Application of Signal Transduction to Anti-Cancer Drug
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
119-131
Author(s):
Shinji Osada and Shigetoyo Saji
Glucuronides in Anti-Cancer Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
139-150
Author(s):
Xi Chen, Bingyuan Wu and Peng George Wang
Current Targets for Anticancer Drug Discovery
Journal:
Current Drug Targets
Volume:
4
Page:
159-179
Author(s):
Nguyen-Hai Nam and Keykavous Parang
Neuropeptides as Autocrine Growth Factors in Cancer Cells
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
495-509
Author(s):
Terry W. Moody, Daniel Chan, Jan Fahrenkrug and Robert T. Jensen
Cancer and Phase II Drug-Metabolizing Enzymes
Journal:
Current Drug Metabolism
Volume:
4
Page:
45-58
Author(s):
S. A. Sheweita and A. K. Tilmisany
Inhibiting Cyclin-Dependent Kinase / Cyclin Activity for the Treatment of Cancer and Cardiovascular Disease
Journal:
Current Pharmaceutical Biotechnology
Volume:
4
Page:
21-37
Author(s):
C. Ivorra, H. Samyn, M. D. Edo, C. Castro, S. M. Sanz-González, A. Diez-Juan and V. Andres